2024 Annual Meeting | C53 - Status Epilepticus Update

Date Sunday 04/14/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | Bluebird 1A

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Clio A. Rubinos, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants should comprehend the pathophysiological rationale for administering essential early-stage medications to prevent the progression of status epilepticus; recognize and address various types and phases of status epilepticus, including NORSE; and develop an approach to managing challenging EEG patterns such as periodic discharges and the ictal-interictal continuum.

This program is supported in part by an educational grant from Marinus Pharmaceuticals, Inc.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM MDT	Introduction	Introduction Clio A. Rubinos, MD
01:05 PM - 01:30 PM MDT	Speaker	Status Epilepticus: The Golden Hour Treatment LUIS O. CABOCLO, MD, PhD
01:30 PM - 01:55 PM MDT	Speaker	Refractory and Super Refractory Status Epilepticus: What Can We Do? Clio A. Rubinos, MD
01:55 PM - 02:20 PM MDT	Speaker	Periodic and Rhythmic Patterns: When to Treat and How? Suzette M. LaRoche, MD, FAAN
02:20 PM - 02:30 PM MDT	Q&A	Questions and Answers Suzette M. LaRoche, MD, FAAN
02:30 PM - 02:40 PM MDT	Speaker	Patient Experience Sharing Video Clio A. Rubinos, MD
02:40 PM - 03:00 PM MDT	Discussion	Interactive Game—Status Patronus: How Would You Treat This Status Epilepticus Patient? With Panel Commentary Clio A. Rubinos, MD, Suzette M. LaRoche, MD, FAAN

Faculty Disclosures
Clio A. Rubinos, MD	Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qualtrics Inc. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity Pharmaceuticals. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Epilepsy Society . Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Marinus Pharmaceutical. Dr. Rubinos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina .
Suzette M. LaRoche, MD, FAAN	Dr. LaRoche has received intellectual property interests from a discovery or technology relating to health care. Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to AAN interests or activities.
LUIS O. CABOCLO, MD, PhD	Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Libbs Phamaceutical. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adium Pharmaceutical. Dr. CABOCLO has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Endogen Pharmaceutical (Brazil). Dr. CABOCLO has stock in Endogen Pharmaceutical (Brazil).